Damora Therapeutics Inc. (DMRA)
NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 20.24 0.00%
DMRA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.25B
- EPS (TTM)
- -$0.25
- Dividend yield
- None
- 52-week range
- 4.95 – 38.33
- Day range
- 18.69 – 20.34
- Volume / Avg
- 488.04K / 542.78K
- Beta
- —
- Shares outstanding
- 61.74M
- Next earnings
- Nov 5, 2026
52-week range
DMRA stock today
Damora Therapeutics (DMRA) closed at $20.24 on Oct 7, up 3.53% (+$0.69), versus the S&P 500's 0.22% decline. At this level, DMRA sits in the middle of its 52-week range of $4.95 to $38.33: 47.2% below the high and 308.9% above the low. Damora Therapeutics has posted a net loss over the last twelve months (EPS of -$0.25), so its P/E ratio is not meaningful.
Damora Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Damora Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.52
Damora Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ORICOric Pharmaceuticals Inc. | 12.01 | +0.25% | $1.24B | vs DMRA |
| NBTXNanobiotix S.A. ADR | 24.62 | -2.42% | $1.25B | vs DMRA |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs DMRA |
| AVLNAvalyn Pharma Inc. | 25.53 | +0.39% | $1.13B | vs DMRA |
| KARDKardigan Inc. | 13.83 | +2.52% | $1.29B | vs DMRA |
| MNKDMannKind Corporation | 3.45 | -7.01% | $1.11B | vs DMRA |
| LBRXLB Pharmaceuticals Inc | 34.16 | -0.29% | $1.10B | vs DMRA |
| JANXJanux Therapeutics Inc. | 17.92 | +6.73% | $1.10B | vs DMRA |
Indexes, lists and sector
Largest Health Care stocks
Damora Therapeutics stock FAQ
What is Damora Therapeutics's stock price today?
DMRA last traded at $20.24 as of Oct 7, 4:00 PM EDT, up 3.53% on the day. Prices are delayed at least 15 minutes.
When is Damora Therapeutics's next earnings date?
Damora Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.52.
What is the DMRA 52-week high?
The 52-week high for DMRA is $38.33 and the 52-week low is $4.95. The stock is currently 47.2% below its high.